ScienceDaily (Mar. 28, 2008) — A dramatic new study published in the most recent issue of Nature questions some of the mechanisms underlying a new class of drugs based on Nobel Prize-winning work designed to fight diseases ranging from macular degeneration to diabetes.
LONDON (Reuters) - A new class of drug that fine tunes the action of genes has been shown to cut cholesterol in monkeys and may fight a range of ills, including hepatitis C and perhaps cancer, scientists said on Wednesday.
4/20/08
dla project
love
